Clinical Trial

Two Intravenous Doses of Ketamine in Reducing the Oculocardiac Reflex in Adult Patients Undergoing Ophthalmic Surgery

Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to evaluate whether a lower dose of ketamine (0.5 mg/kg IV) may be as effective as a higher dose (0.75 mg/kg IV) in reducing oculocardiac reflex (OCR) incidence in adult patients undergoing ophthalmic surgery.
Trial Details
NCT Number NCT07708740
Lead Sponsor Cairo University
Conditions Ketamine, Oculocardiac Reflex, Ophthalmic Surgery
Enrollment 40 participants
Start Date 2026-07-01
Primary Completion 2027-12-30 (estimated)
Study Completion 2027-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-16